CAAM
RDY icon

Cape Ann Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Cape Ann Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,000
Closed -$251K – 8
2022
Q3 		$251K Hold
24,000
– – 0.3% 8
2022
Q2 		$266K Buy
+24,000
New +$261K 0.15% 8

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Cape Ann Asset Management's RDY Position: Q4 2022 in Review

Cape Ann Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2022, closing a stake of 24,000 shares — an estimated $251K sold.

Cape Ann Asset Management first reported a position in RDY in Q2 2022 and held it in 2 quarters. The position peaked at $266K in Q2 2022. 161 funds tracked by Wall St. Rank hold RDY as of Q4 2022.

  • Cape Ann Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2022 after selling out during the quarter.
  • Cape Ann Asset Management sold 24,000 Dr. Reddy's Laboratories shares in Q4 2022, an estimated $251K.
  • Cape Ann Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2022 and held it in 2 quarters.
  • Cape Ann Asset Management's Dr. Reddy's Laboratories position peaked at $266K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2022.

Based on Cape Ann Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.